BRD9 and cancer: BRD9, a member of subfamily IV, is a protein identified as a dedicated member of the mammalian SWI/SNF complex; it maintains and facilitates oncogenic transcription directly by recognizing the acetylated lysine on post-translationally modified histone proteins, contributing to cancer cell proliferation and survival [18].